Background
Methods
Study population
Clinical measurements
Gold standard
Routine local measurements
Urine markers
Definitions of outcome categories
Variables
Statistical analysis
Variables | Case-group 1 | Case-group 2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Model 1
|
Model 2
|
Model 3
|
Model 4
|
Model 5
|
Model 6
|
Model 7
|
Model 8
|
Model 9
|
Model 10
| |
Age | X | X | X | X | X | X | X | X | X | X |
Season | X | X | X | X | X | X | X | X | X | X |
Occupation (outdoor work) | X | X | X | X | X | X | X | X | X | X |
UACR | X | X | X | X | X | X | X | X | X | X |
UNGAL | X | X | X | X | X | |||||
eGFRScr at baseline | X | X | X | X | X | X | X | X | X | X |
eGFRScr at 6 months | X | X | X | X | ||||||
eGFRScr at 12 months | X | X | X | X |
Results
Agreement between clinical measurements – Routine eGFRScr-Nicaragua compared to the gold-standard eGFRScr-Oxford
General characteristics stratified by kidney function trajectories
Trajectories of the decline in kidney function | N | Age at baseline (Mean; SD) | Serum creatinine level at baseline‡ (Median; IQR) | eGFRScr at baseline‡ (Median; IQR) | eGFRScr-Scys at baseline† (Median; IQR) | Urinary NGAL level at baseline◊ (Median; IQR) | UACR ≥30 mg/dL at baseline◊ (n; %) | Outdoor work at baseline (n; %) |
---|---|---|---|---|---|---|---|---|
Stable kidney function (−0.6 mL/min/1.73 m2/year) | 213 | 23.6 ± 3.89 | 0.76 (0.57–0.76) | 131 (124–140) | 118 (108–125) | 5.04 (4.7–5.4) | 10 (4.7) | 151 (70.9) |
Rapid decline in kidney function (− 18.2 mL/min/1.73 m2/year) | 25 | 23.3 ± 3.65 | 0.66 (0.47–0.76) | 132 (123–152) | 117 (103–124) | 5.20 (5.0–5.5) | 0 (0) | 24 (96.0) |
Renal dysfunction (− 3.8 mL/min/1.73 m2/year) | 25 | 25.4 ± 2.97 | 1.23 (1.14–1.52) | 80 (62–91) | 56 (49–68) | 5.7 (5.5–5.7) | 4 (16.0) | 19 (76.0) |
Total | 263 | 23.7 ± 3.82 | 0.76 (0.66–0.85) | 129 (121–139) | 116 (102–125) | 5.20 (4.9–5.7) | 14 (5.3) | 194 (73.8) |